Search

everythinglearnresearchcommunity

for

Search:↓

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

A new CBD topical formulation may effectively and safely treat alopecia.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Solubility in skin changes with hydration, affecting chemical absorption.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

The research found that nanoparticles coated with chitosan improved the skin penetration of the drug finasteride.

Chitosan-decorated nanoparticles improve skin delivery of finasteride, with PS404-b-PAA63 being most effective.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Microneedles could be a better and easier way to regrow hair.

Different hair loss treatment ingredients work well with TrichoTech™ vehicles for 3 to 6 months, making them good for use in hair treatments.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Using β-cyclodextrin derivatives improves the solubility and bioavailability of steroidal drugs.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Droplet-based microfluidics improves delivery of bioactive compounds in food using precise encapsulation and release.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Tadalafil and Finasteride may help treat aggressive melanoma.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Combining herbal medicines with modern delivery systems may improve alopecia treatment.